Divergent synthesis yields tetrafluoroethylene-containing tetrahydrofuran and dihydropyran derivatives, indicating new chemical pathways.
A divergent synthetic methodology for tetrafluoroethylene (CF2CF2)-containing tetrahydrofurans (THFs) and dihydropyrans (DHPs), employing 4-bromo-2,2,3,3-tetrafluoro-4-penten-1-ol derivatives as common synthetic intermediates, has been developed. Mechanistic studies indicate that the reaction proceeds chemoselectively, either via copper-catalyzed Ullmann-type intramolecular O-vinylation or through tandem CF2CF2 group-promoted β-elimination followed by 6-endo-dig cycloisomerization. Further investigations demonstrate that both cyclic ethers can be diastereoselectively transformed into a wide range of CF2CF2-containing C-glycoside derivatives.
No takes yet. Share an insight, caveat, or question.
Yasui et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: